NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Acadia Healthcare (ACHC) was initiated with a buy rating at Cantor Fitzgerald. $35 price target. Company should benefit from a better regulatory environment and can deliver above-average growth, Cantor Fitzgerald said.
Affiliated Managers (AMG) was upgraded at Goldman to buy. Company can generate solid organic growth, Goldman said. $170 price target.
Carnival (CCL) was downgraded to hold at TheStreet Ratings.Coach (COH - Get Report) was upgraded to buy from neutral at Citigroup. The stock has transitioned to a value stock and the risk is partially priced in, Citi said. Price target remains $56. Cash America International (CSH) was downgraded at Sterne Agee to neutral. Valuation is full. The stock is up 33% year-to-date and within 4% of Stern Agee's new price target of $55. Discover (DFS) was upgraded at FBR Capital Markets to outperform from market perform. $48 price target. Estimates also boosted, given higher receivables and interest income, as well as lower credit costs, FBR Capital Markets said. Dril-Quip (DRQ) was initiated with a buy rating at Lazard Capital Markets. $105 price target. Company can deliver 25% annual earnings growth over the next two years. First Cash Financial Services (FCFS) was downgraded at Sterne Agee to neutral. The call is based on a fair valuation, Sterne Agee said. Fortress (FIG - Get Report) was upgraded at Goldman Sachs to buy. Legacy funds have recovered well, Goldman said. Freescale (FSL) was downgraded at Bernstein Research to market perform from outperform. Valuation call, based on an $18 price target, Bernstein said. Genesco (GCO) was upgraded at Piper Jaffray to overweight from neutral. $73 price target. Company has strong long-term earnings potential, Piper Jaffray said. Hasbro (HAS) was downgraded at Keybanc to hold from buy. The stock has doubled the market year-to-date and the company lacks near-term catalysts, Keybanc said. Oracle (ORCL) was upgraded at Canaccord Genuity to buy from hold. $42 price target. Stock sets up well for a 10%-20% run, Canaccord Genuity said. Stericycle (SRCL) was initiated with a buy rating at Goldman Sachs. $115 price target. Company can continue to gain domestic market share and also grow outside of the U.S., Goldman said.